Genetic Testing After a Terminal Diagnosis—Providing Purpose J Solimine, JAMA Oncology, May 30, 2019

Main|Search|PHGKB




Last Posted: May 31, 2019

---

• Genetic Testing After a Terminal Diagnosis—Providing Purpose
  J Solimine, JAMA Oncology, May 30, 2019
• Personalized Pancreatic Cancer Management: A Systematic Review of How Machine Learning Is Supporting Decision-making.
  Bradley Alison et al. Pancreas 48(5) 598-604
• Pharmacogenetics of treatments for pancreatic cancer.
  El Hassouni Btissame et al. Expert opinion on drug metabolism & toxicology 2019 May
• Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.
  Dreyer Stephan B et al. Chinese clinical oncology 2019 Apr 8(2) 16
• A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma.
  Zhang Huo et al. Journal of Cancer 2019 10(6) 1550-1559
• Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
  Wei Chunmi et al. Journal of cellular biochemistry 2019 Apr
• Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
  Leof Emma R et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Apr
• Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result.
  Zhu Xuan et al. Public health genomics 2019 Apr 21(3-4) 154-163
• Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
  Marini Francesca et al. Orphanet journal of rare diseases 2018 13(1) 205
• Analysis of the CDKN2A gene in FAMMM Syndrome families reveals early age of onset for additional syndromic cancers.
  Middlebrooks Candace D et al. Cancer research 2019 Apr

more